Figure 6From: Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cellsBar graphs showing viability after cisplatin or simultaneous treatment with cisplatin and quercetin in HK1 (A) and C666-1 (B) cells, determined by the MTS assay. The control group on the extreme left is assigned 100% viability. The combination of quercetin and cisplatin is more active than cisplatin alone. Results are presented as average percentage viable ± sd.Back to article page